Zurich Cantonal Bank
NAMS icon

Zurich Cantonal Bank’s NewAmsterdam Pharma NAMS Stock Holding History

Zurich Cantonal Bank’s Portfolio NAMS Stock Details NAMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-19,804
Closed -$695K – 3152
2025
Q4 		$695K Buy
+19,804
New +$721K ﹤0.01% 1570

Other funds holding NAMS

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return

Zurich Cantonal Bank's NAMS Position: Q1 2026 in Review

Zurich Cantonal Bank opened a new position in NewAmsterdam Pharma (NAMS) in Q1 2026: 20,921 shares worth $670K. The stake represents ﹤0.01% of the portfolio and ranks #1657 among its holdings. This is a return to the name: Zurich Cantonal Bank previously reported a position in NAMS as recently as Q3 2025.

Zurich Cantonal Bank first reported a position in NAMS in Q4 2024 and has held it in 5 quarters since. 170 funds tracked by Wall St. Rank hold NAMS as of Q1 2026.

  • Zurich Cantonal Bank held 20,921 shares of NewAmsterdam Pharma worth $670K as of Q1 2026.
  • NewAmsterdam Pharma was a new Zurich Cantonal Bank position in Q1 2026.
  • NewAmsterdam Pharma made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q1 2026, its #1657 holding.
  • Zurich Cantonal Bank first reported a position in NewAmsterdam Pharma in Q4 2024 and has held it in 5 quarters since.
  • 170 funds tracked by Wall St. Rank held NewAmsterdam Pharma as of Q1 2026.

Based on Zurich Cantonal Bank's 13F filing for Q1 2026, filed 15 May 2026.